Sterling Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Sterling Capital Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.18M	Buy	17,337 +2,722	+19%	+$596K	0.07%	225
2026 Q1	$2.76M	Sell	14,615 -2,843	-16%	-$497K	0.05%	266
2025 Q4	$2.97M	Buy	17,458 +11,121	+175%	+$1.7M	0.05%	281
2025 Q3	$835K	Sell	6,337 -404	-6%	-$48.5K	0.01%	694
2025 Q2	$715K	Sell	6,741 -6,863	-50%	-$746K	0.01%	757
2025 Q1	$1.69M	Sell	13,604 -1,611	-11%	-$210K	0.03%	415
2024 Q4	$1.87M	Buy	15,215 +1,260	+9%	+$149K	0.03%	435
2024 Q3	$1.55M	Buy	+13,955	New	+$1.53M	0.02%	447
2019 Q3	$2.13M	Sell	16,636 -7,417	-31%	-$994K	0.02%	402
2019 Q2	$3.43M	Buy	24,053 +18,550	+337%	+$2.49M	0.03%	298
2019 Q1	$787K	Sell	5,503 -28,017	-84%	-$3.65M	0.01%	669
2018 Q4	$4.16M	Buy	+33,520	New	+$4.97M	0.05%	245
2014 Q4	–	Sell	-10,808	Closed	-$1.74M	–	934
2014 Q3	$1.74M	Buy	10,808 +1,600	+17%	+$246K	0.02%	426
2014 Q2	$1.35M	Hold	9,208	–	–	0.01%	514
2014 Q1	$1.28M	Sell	9,208 -1,815	-16%	-$273K	0.01%	499
2013 Q4	$1.4M	Buy	11,023 +65	+0.6%	+$6.73K	0.01%	313
2013 Q3	$1.01M	Buy	+10,958	New	+$884K	0.01%	259

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Sterling Capital Management's JAZZ Position: Q2 2026 in Review

Sterling Capital Management increased its Jazz Pharmaceuticals (JAZZ) stake by 19% in Q2 2026, buying an estimated $596K and bringing the position to 17,337 shares worth $4.18M. The position accounts for 0.07% of the portfolio, ranked #225.

Sterling Capital Management first reported a position in JAZZ in Q3 2013 and has held it in 17 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Sterling Capital Management held 17,337 shares of Jazz Pharmaceuticals worth $4.18M as of Q2 2026.
Sterling Capital Management bought 2,722 Jazz Pharmaceuticals shares in Q2 2026, an estimated $596K.
Jazz Pharmaceuticals made up 0.07% of Sterling Capital Management's portfolio in Q2 2026, its #225 holding.
Sterling Capital Management first reported a position in Jazz Pharmaceuticals in Q3 2013 and has held it in 17 quarters since.
646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.